| 1 |
Prospective study of patients with inflammatory back pain, clinical characteristics and treatment response in ankylosing spondylitis in two centers of rheumatology in South India |
|
| | Subramanian Nallasivan, Dhivya Thiyagarajan, Abirami Manivannan | | | Indian Journal of Rheumatology. 2022; 0(0): 0 | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
Ixekizumab: an IL-17A inhibitor for the treatment for the treatment of axial spondylarthritis |
|
| | Stephanie R Harrison,Helena Marzo-Ortega | | | Expert Review of Clinical Immunology. 2021; | | | [Pubmed] [Google Scholar] [DOI] | |
|
